1 | 2010 | 8,982 |
2 | 2009 | 8,448 |
3 | 2011 | 8,404 |
4 | 2012 | 7,687 |
5 | 2008 | 7,493 |
6 | 2013 | 5,088 |
7 | 2014 | 2,255 |
8 | 2015 | 575 |
9 | 2010. | 13 |
10 | pulmonol | 10 |
11 | sgsb100 | 7 |
12 | 1985-2008 | 6 |
13 | 2014. | 5 |
14 | 3μm | 5 |
15 | 2012.we | 4 |
16 | 2013.we | 4 |
17 | 2014.selection | 4 |
18 | 2015genetics | 4 |
19 | bayar | 4 |
20 | raecs | 4 |
21 | tacmr | 4 |
22 | utex259 | 4 |
23 | ε4- | 4 |
24 | 2001. | 3 |
25 | 2003a | 3 |
26 | 400g | 3 |
27 | 6/30/2006 | 3 |
28 | aoedp | 3 |
29 | cncm-i-3699 | 3 |
30 | isofluran | 3 |
31 | panchkula | 3 |
32 | 0.95μg/ml | 2 |
33 | 1.0:1 | 2 |
34 | 11,513 | 2 |
35 | 12/2004 | 2 |
36 | 16-dsa | 2 |
37 | 2002/10 | 2 |
38 | 2003-4 | 2 |
39 | 2014genetics | 2 |
40 | 95kda | 2 |
41 | a/pc | 2 |
42 | adl-bi | 2 |
43 | brachydactylia | 2 |
44 | c-l- | 2 |
45 | dexmedetomidine-etomidate | 2 |
46 | gsk-clinicalstudyregister.com | 2 |
47 | hyper-thyroidism | 2 |
48 | monopoiesis | 2 |
49 | mupinensis | 2 |
50 | nct00175877 | 2 |
51 | nct00325897 | 2 |
52 | nootkatone | 2 |
53 | pgs2 | 2 |
54 | spiromyces | 2 |
55 | supervene | 2 |
56 | sweets/snacks | 2 |
57 | tsl5 | 2 |
58 | wge | 2 |
59 | zhuling | 2 |
60 | '89 | 1 |
61 | '96 | 1 |
62 | 01,2000 | 1 |
63 | 01,2008 | 1 |
64 | 1,1989 | 1 |
65 | 1,1994 | 1 |
66 | 10,2008 | 1 |
67 | 11405 | 1 |
68 | 11–29 | 1 |
69 | 13,2013 | 1 |
70 | 16:374 | 1 |
71 | 17:581-584 | 1 |
72 | 1978-86 | 1 |
73 | 19867 | 1 |
74 | 1996b | 1 |
75 | 1997.conclusions | 1 |
76 | 1998. | 1 |
77 | 2004.primarily | 1 |
78 | 2005.-rbj | 1 |
79 | 2005.2 | 1 |
80 | 2005.3 | 1 |
81 | 2006* | 1 |
82 | 2006-present | 1 |
83 | 2007.a | 1 |
84 | 2007.this | 1 |
85 | 2007.we | 1 |
86 | 2009-639 | 1 |
87 | 2009.we | 1 |
88 | 20098 | 1 |
89 | 2010.participants | 1 |
90 | 2011,135 | 1 |
91 | 2011.children | 1 |
92 | 2011https | 1 |
93 | 2012.tapps | 1 |
94 | 2012.total | 1 |
95 | 2013.additionally | 1 |
96 | 2013.patients | 1 |
97 | 2013.recruiting | 1 |
98 | 2013.selection | 1 |
99 | 2014.last | 1 |
100 | 2014.the | 1 |
101 | 2014.we | 1 |
102 | 2015.we | 1 |
103 | 20:279-287 | 1 |
104 | 21,2010 | 1 |
105 | 23rd-29th | 1 |
106 | 27,2008 | 1 |
107 | 31,2010 | 1 |
108 | 43:540-555 | 1 |
109 | 6,1996 | 1 |
110 | 7th-11th | 1 |
111 | 8th-12th | 1 |
112 | digotica | 1 |
113 | gii.21 | 1 |
114 | hla-b*39 | 1 |
115 | merula | 1 |
116 | m½ | 1 |
117 | nchu | 1 |
118 | northwesterly | 1 |
119 | rivadavia | 1 |
120 | sattian | 1 |
121 | self-appropriation | 1 |
122 | sokołowski | 1 |
123 | spp.each | 1 |
124 | sędziak | 1 |
1 | '89 | 1 |
2 | '96 | 1 |
3 | 0.95μg/ml | 2 |
4 | 01,2000 | 1 |
5 | 01,2008 | 1 |
6 | 1,1989 | 1 |
7 | 1,1994 | 1 |
8 | 1.0:1 | 2 |
9 | 10,2008 | 1 |
10 | 11,513 | 2 |
11 | 11405 | 1 |
12 | 11–29 | 1 |
13 | 12/2004 | 2 |
14 | 13,2013 | 1 |
15 | 16-dsa | 2 |
16 | 16:374 | 1 |
17 | 17:581-584 | 1 |
18 | 1978-86 | 1 |
19 | 1985-2008 | 6 |
20 | 19867 | 1 |
21 | 1996b | 1 |
22 | 1997.conclusions | 1 |
23 | 1998. | 1 |
24 | 2001. | 3 |
25 | 2002/10 | 2 |
26 | 2003-4 | 2 |
27 | 2003a | 3 |
28 | 2004.primarily | 1 |
29 | 2005.-rbj | 1 |
30 | 2005.2 | 1 |
31 | 2005.3 | 1 |
32 | 2006* | 1 |
33 | 2006-present | 1 |
34 | 2007.a | 1 |
35 | 2007.this | 1 |
36 | 2007.we | 1 |
37 | 2008 | 7,493 |
38 | 2009 | 8,448 |
39 | 2009-639 | 1 |
40 | 2009.we | 1 |
41 | 20098 | 1 |
42 | 2010 | 8,982 |
43 | 2010. | 13 |
44 | 2010.participants | 1 |
45 | 2011 | 8,404 |
46 | 2011,135 | 1 |
47 | 2011.children | 1 |
48 | 2011https | 1 |
49 | 2012 | 7,687 |
50 | 2012.tapps | 1 |
51 | 2012.total | 1 |
52 | 2012.we | 4 |
53 | 2013 | 5,088 |
54 | 2013.additionally | 1 |
55 | 2013.patients | 1 |
56 | 2013.recruiting | 1 |
57 | 2013.selection | 1 |
58 | 2013.we | 4 |
59 | 2014 | 2,255 |
60 | 2014. | 5 |
61 | 2014.last | 1 |
62 | 2014.selection | 4 |
63 | 2014.the | 1 |
64 | 2014.we | 1 |
65 | 2014genetics | 2 |
66 | 2015 | 575 |
67 | 2015.we | 1 |
68 | 2015genetics | 4 |
69 | 20:279-287 | 1 |
70 | 21,2010 | 1 |
71 | 23rd-29th | 1 |
72 | 27,2008 | 1 |
73 | 31,2010 | 1 |
74 | 3μm | 5 |
75 | 400g | 3 |
76 | 43:540-555 | 1 |
77 | 6,1996 | 1 |
78 | 6/30/2006 | 3 |
79 | 7th-11th | 1 |
80 | 8th-12th | 1 |
81 | 95kda | 2 |
82 | a/pc | 2 |
83 | adl-bi | 2 |
84 | aoedp | 3 |
85 | bayar | 4 |
86 | brachydactylia | 2 |
87 | c-l- | 2 |
88 | cncm-i-3699 | 3 |
89 | dexmedetomidine-etomidate | 2 |
90 | digotica | 1 |
91 | gii.21 | 1 |
92 | gsk-clinicalstudyregister.com | 2 |
93 | hla-b*39 | 1 |
94 | hyper-thyroidism | 2 |
95 | isofluran | 3 |
96 | merula | 1 |
97 | monopoiesis | 2 |
98 | mupinensis | 2 |
99 | m½ | 1 |
100 | nchu | 1 |
101 | nct00175877 | 2 |
102 | nct00325897 | 2 |
103 | nootkatone | 2 |
104 | northwesterly | 1 |
105 | panchkula | 3 |
106 | pgs2 | 2 |
107 | pulmonol | 10 |
108 | raecs | 4 |
109 | rivadavia | 1 |
110 | sattian | 1 |
111 | self-appropriation | 1 |
112 | sgsb100 | 7 |
113 | sokołowski | 1 |
114 | spiromyces | 2 |
115 | spp.each | 1 |
116 | supervene | 2 |
117 | sweets/snacks | 2 |
118 | sędziak | 1 |
119 | tacmr | 4 |
120 | tsl5 | 2 |
121 | utex259 | 4 |
122 | wge | 2 |
123 | zhuling | 2 |
124 | ε4- | 4 |
1 | 2006* | 1 |
2 | ε4- | 4 |
3 | c-l- | 2 |
4 | 2010. | 13 |
5 | 2001. | 3 |
6 | 2014. | 5 |
7 | 1998. | 1 |
8 | 01,2000 | 1 |
9 | sgsb100 | 7 |
10 | 2002/10 | 2 |
11 | 2010 | 8,982 |
12 | 21,2010 | 1 |
13 | 31,2010 | 1 |
14 | 2011 | 8,404 |
15 | gii.21 | 1 |
16 | 1.0:1 | 2 |
17 | 2005.2 | 1 |
18 | 2012 | 7,687 |
19 | pgs2 | 2 |
20 | 2005.3 | 1 |
21 | 2013 | 5,088 |
22 | 13,2013 | 1 |
23 | 11,513 | 2 |
24 | 2003-4 | 2 |
25 | 12/2004 | 2 |
26 | 2014 | 2,255 |
27 | 16:374 | 1 |
28 | 17:581-584 | 1 |
29 | 1,1994 | 1 |
30 | 11405 | 1 |
31 | 2015 | 575 |
32 | 2011,135 | 1 |
33 | 43:540-555 | 1 |
34 | tsl5 | 2 |
35 | 6/30/2006 | 3 |
36 | 1978-86 | 1 |
37 | '96 | 1 |
38 | 6,1996 | 1 |
39 | 19867 | 1 |
40 | nct00175877 | 2 |
41 | 20:279-287 | 1 |
42 | nct00325897 | 2 |
43 | 2008 | 7,493 |
44 | 10,2008 | 1 |
45 | 01,2008 | 1 |
46 | 27,2008 | 1 |
47 | 1985-2008 | 6 |
48 | 20098 | 1 |
49 | 2009 | 8,448 |
50 | 11–29 | 1 |
51 | hla-b*39 | 1 |
52 | 2009-639 | 1 |
53 | utex259 | 4 |
54 | '89 | 1 |
55 | 1,1989 | 1 |
56 | cncm-i-3699 | 3 |
57 | 2007.a | 1 |
58 | 2003a | 3 |
59 | digotica | 1 |
60 | 95kda | 2 |
61 | brachydactylia | 2 |
62 | rivadavia | 1 |
63 | panchkula | 3 |
64 | merula | 1 |
65 | 16-dsa | 2 |
66 | 1996b | 1 |
67 | a/pc | 2 |
68 | wge | 2 |
69 | 2014.the | 1 |
70 | supervene | 2 |
71 | nootkatone | 2 |
72 | dexmedetomidine-etomidate | 2 |
73 | 2012.we | 4 |
74 | 2013.we | 4 |
75 | 2014.we | 1 |
76 | 2015.we | 1 |
77 | 2007.we | 1 |
78 | 2009.we | 1 |
79 | 400g | 3 |
80 | zhuling | 2 |
81 | 2013.recruiting | 1 |
82 | spp.each | 1 |
83 | 7th-11th | 1 |
84 | 8th-12th | 1 |
85 | 23rd-29th | 1 |
86 | adl-bi | 2 |
87 | sokołowski | 1 |
88 | 2005.-rbj | 1 |
89 | sędziak | 1 |
90 | 2012.total | 1 |
91 | 0.95μg/ml | 2 |
92 | pulmonol | 10 |
93 | gsk-clinicalstudyregister.com | 2 |
94 | hyper-thyroidism | 2 |
95 | 3μm | 5 |
96 | sattian | 1 |
97 | isofluran | 3 |
98 | 2011.children | 1 |
99 | self-appropriation | 1 |
100 | 2013.selection | 1 |
101 | 2014.selection | 4 |
102 | aoedp | 3 |
103 | bayar | 4 |
104 | tacmr | 4 |
105 | raecs | 4 |
106 | 2014genetics | 2 |
107 | 2015genetics | 4 |
108 | spiromyces | 2 |
109 | 2007.this | 1 |
110 | monopoiesis | 2 |
111 | mupinensis | 2 |
112 | sweets/snacks | 2 |
113 | 1997.conclusions | 1 |
114 | 2012.tapps | 1 |
115 | 2011https | 1 |
116 | 2010.participants | 1 |
117 | 2013.patients | 1 |
118 | 2006-present | 1 |
119 | 2014.last | 1 |
120 | nchu | 1 |
121 | 2004.primarily | 1 |
122 | 2013.additionally | 1 |
123 | northwesterly | 1 |
124 | m½ | 1 |